---
$id: https://graph.org.ai/products/commodity/51111767
$type: Product
source: UNSPSC
code: "51111767"
title: "Vincristine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vincristine

**UNSPSC Code**: 51111767
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C46H56N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5J49Q6B70F, chemically known as vincaleukoblastine, 22-oxo- but generally known as vincristine, which bears US NIH Compound Identifier 5978. European Medicines Agency schedules Vincristine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00059MIG. The term VINCRISTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules vincristine in its Anatomical Therapeutic Chemical (ATC) Classification. VINCRISTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vincristine under HS 29399900 and SITC 54149. As of Q4 2014, VINCRISTINE remains the US FDA Preferred Term for this commodity. Vincristine bears US NLM identifiers UMLS ID C0042679 and NCI Concept Code C933. SMILES: O(C1C2(C3N(CCC43C(N(C3C4CC(C(OC)C3)C3(CC4CC(O)(CN(C4)CCC4C3[NH]C3C4CCCC3)CC)C(=O)OC)C=O)C1(O)C(=O)OC)CC=C2)CC)C(=O)C.

